Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Saranya Akumalla"'
Autor:
Daniel P. Silver, Michele Sue-Ann Woo, Veda N. Giri, Saranya Akumalla, Alison Greidinger, Scott W. Keith, Charnita Zeigler-Johnson, Susan Miller-Samuel
Publikováno v:
JCO Precis Oncol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22a3e7fab42b64c98bab5c2929adacb2
https://doi.org/10.1200/po.19.00241
https://doi.org/10.1200/po.19.00241
Autor:
Evgeny Yakirevich, Garrett M. Frampton, Claire Edgerly, Russell Madison, Arjun Vasant Balar, Shridar Ganesan, Jeffrey S. Ross, Alexa B. Schrock, Saranya Akumalla, Douglas I. Lin, Vincent A. Miller, Margaret Rosenzweig, Rachel L. Erlich, Siraj M. Ali
Publikováno v:
Oncology. 98:905-912
Purpose: Perivascular epithelioid cell tumor (PEComa) is a rare mesenchymal soft tissue neoplasm often linked to mTOR pathway activation via TSC2 mutation. We analyzed a series of 31 consecutive metastatic PEComa (mPEComa) cases using a combined DNA/
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::15dfd50b50cfcde739cee60cb9e5492b
https://doi.org/10.1159/000510241
https://doi.org/10.1159/000510241
Autor:
A. Verma, Reham Abdel-Wahab, Saranya Akumalla, Brian M. Alexander, S.M. Ali, Alexa B. Schrock, J. Lee, J.S. Ross, J. Newburg, V.A. Miller, Russell Madison, Jon Chung, Milind Javle, G.M. Frampton
Publikováno v:
Annals of Oncology. 30:v275
Background GBAC is an aggressive neoplasm with an abysmal 5-year survival rate and no approved targeted therapies. Incidence of GBAC varies greatly across global geographical regions, with highest reported rates in South and East Asia. We evaluated w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::be7a9742269c2f9291892a9cf3426d5c
https://doi.org/10.1093/annonc/mdz247.045
https://doi.org/10.1093/annonc/mdz247.045